Skip to main navigation Skip to search Skip to main content

A 6-month multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age-and body weight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to <18 years of age, with chronic kidney disease and proteinuria

  • Johnstone, Lilian (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date21/03/22 → 20/03/27

Keywords

  • multicentre trial
  • kidney disease
  • treatment safety
  • treatment efficacy
  • randomised controlled trial (RCT)

Clinical Trial Phase

  • Phase III (a & b)